Trial Profile
A pilot study of Strattera treatment in children with attention-deficit/hyperactivity disorder who have poor response to stimulant therapy
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2005
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 05 Nov 2005 New trial record.